Northern Trust Corp Biotechnology

Northern Trust Corp

$658 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LTRN Lantern Pharma Inc.	$45.6M	$55,000 0.0% of portfolio	15,589	Q1 2025 Added 21.67%
AIKI A Ikido Pharma Inc.	$20.8M	$48,000 0.0% of portfolio	12,864	Q1 2025 New
XLO Xilio Therapeutics, Inc.	$18.4M	$47,000 0.0% of portfolio	66,609	Q1 2025 Added 69.89%
LYRA Lyra Therapeutics, Inc.	$255M	$43,000 0.0% of portfolio	332,639	Q1 2025 Added 16.18%
MIST Milestone Pharmaceuticals Inc.	$47.4M	$42,000 0.0% of portfolio	53,001	Q1 2025 Reduced 8.79%
PASG Passage Bio, Inc.	$385M	$39,000 0.0% of portfolio	111,981	Q1 2025 Added 79.24%
ALLK Allakos Inc.	$28M	$37,000 0.0% of portfolio	164,355	Q4 2024 Added 10.19%
BCAB Bio Atla, Inc.	$13.4M	$35,000 0.0% of portfolio	100,828	Q1 2025 Added 0.01%
LEXX Lexaria Bioscience Corp.	$5.71M	$31,000 0.0% of portfolio	18,389	Q1 2024 New
ARMP Armata Pharmaceuticals, Inc.	$90M	$28,000 0.0% of portfolio	19,273	Q2 2024 Reduced 0.1%
CVM Cel Sci Corp	$294M	$27,000 0.0% of portfolio	118,312	Q2 2024 Reduced 0.06%
RNXT Renovo Rx, Inc.	$11.5M	$26,000 0.0% of portfolio	26,776	Q1 2025 New
GLYC Glycomimetics Inc	$823M	$24,000 0.0% of portfolio	116,985	Q3 2024 Reduced 8.46%
PMCB Pharma Cyte Biotech, Inc.	$20.1M	$24,000 0.0% of portfolio	19,208	Q2 2024 Reduced 0.11%
RLYB Rallybio Corp	$16.7M	$24,000 0.0% of portfolio	38,124	Q1 2025 Reduced 48.2%
BYSI Beyond Spring Inc.	$74.7M	$24,000 0.0% of portfolio	16,705	Q3 2024 Reduced 1.1%
NXTC Next Cure, Inc.	$163M	$22,000 0.0% of portfolio	47,493	Q4 2024 Reduced 0.15%
CGTX Cognition Therapeutics Inc	$18.6M	$19,000 0.0% of portfolio	47,485	Q1 2024 Added 54.56%
BOLT Bolt Biotherapeutics, Inc.	$241M	$16,000 0.0% of portfolio	40,895	Q2 2024 Reduced 0.27%
RLMD Relmada Therapeutics, Inc.	$19.2M	$16,000 0.0% of portfolio	59,571	Q1 2025 Reduced 29.32%
ATHA Athira Pharma, Inc.	$16.6M	$15,000 0.0% of portfolio	53,609	Q2 2024 Added 0.73%
INAB In8 Bio, Inc.	$57.8M	$15,000 0.0% of portfolio	93,420	Q4 2024 Added 211.35%
EQ Equillium, Inc.	$13.1M	$13,000 0.0% of portfolio	35,019	Q2 2024 Reduced 0.09%
ACXP Acurx Pharmaceuticals, Inc.	$5.08M	$10,000 0.0% of portfolio	27,286	Q2 2024 Added 59.07%
ADAP Adaptimmune Therapeutics PLC	$53.9M	$10,000 0.0% of portfolio	51,333	Q3 2024 Reduced 1.02%
AIM Aim Immuno Tech Inc.	$404M	$10,000 0.0% of portfolio	85,119	Q2 2024 Reduced 0.1%
SNSE Sensei Biotherapeutics, Inc.	$212M	$10,000 0.0% of portfolio	25,983	Q2 2024 Reduced 0.25%
SPRB Spruce Biosciences, Inc.	$2.83M	$9,000 0.0% of portfolio	32,721	Q1 2025 Reduced 59.26%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	487,043	Q1 2025 Added 1.86%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.